Found 3 hits Enz. Inhib. hit(s) with Target = 'Glucagon receptor' and Ligand = 'BDBM50007228' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007228
(CHEMBL3238219)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cccc(F)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(7.91,-30.88,;7.89,-29.34,;6.55,-28.59,;6.56,-30.1,;9.22,-28.56,;9.2,-27.02,;10.52,-26.23,;10.47,-24.7,;11.68,-23.74,;13.16,-24.16,;11.15,-22.3,;9.6,-22.36,;9.19,-23.83,;8,-22.85,;6.56,-23.38,;6.29,-24.9,;7.48,-25.88,;8.93,-25.35,;4.85,-25.43,;3.67,-24.45,;3.41,-25.96,;4.59,-26.95,;11.92,-20.97,;13.47,-20.98,;14.24,-19.65,;13.48,-18.31,;11.94,-18.3,;11.17,-16.96,;11.16,-19.63,;11.85,-27.02,;11.83,-28.56,;13.15,-29.35,;14.5,-28.59,;14.52,-27.06,;13.19,-26.27,;15.82,-29.39,;15.8,-30.92,;17.16,-28.63,;18.49,-29.42,;19.83,-28.66,;21.22,-29.3,;22.27,-28.17,;21.51,-26.82,;20,-27.13,)| Show InChI InChI=1S/C34H44FN7O2/c1-32(2,3)17-16-27(22-10-12-23(13-11-22)30(43)36-21-28-38-40-41-39-28)42-31(44)29(24-8-7-9-26(35)20-24)37-34(42)18-14-25(15-19-34)33(4,5)6/h7-13,20,25,27H,14-19,21H2,1-6H3,(H,36,43)(H,38,39,40,41)/t25-,27-,34-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from recombinant human GCGR expressed in CHO cells after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Mus musculus) | BDBM50007228
(CHEMBL3238219)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cccc(F)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(7.91,-30.88,;7.89,-29.34,;6.55,-28.59,;6.56,-30.1,;9.22,-28.56,;9.2,-27.02,;10.52,-26.23,;10.47,-24.7,;11.68,-23.74,;13.16,-24.16,;11.15,-22.3,;9.6,-22.36,;9.19,-23.83,;8,-22.85,;6.56,-23.38,;6.29,-24.9,;7.48,-25.88,;8.93,-25.35,;4.85,-25.43,;3.67,-24.45,;3.41,-25.96,;4.59,-26.95,;11.92,-20.97,;13.47,-20.98,;14.24,-19.65,;13.48,-18.31,;11.94,-18.3,;11.17,-16.96,;11.16,-19.63,;11.85,-27.02,;11.83,-28.56,;13.15,-29.35,;14.5,-28.59,;14.52,-27.06,;13.19,-26.27,;15.82,-29.39,;15.8,-30.92,;17.16,-28.63,;18.49,-29.42,;19.83,-28.66,;21.22,-29.3,;22.27,-28.17,;21.51,-26.82,;20,-27.13,)| Show InChI InChI=1S/C34H44FN7O2/c1-32(2,3)17-16-27(22-10-12-23(13-11-22)30(43)36-21-28-38-40-41-39-28)42-31(44)29(24-8-7-9-26(35)20-24)37-34(42)18-14-25(15-19-34)33(4,5)6/h7-13,20,25,27H,14-19,21H2,1-6H3,(H,36,43)(H,38,39,40,41)/t25-,27-,34-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from GCGR in mouse liver membranes after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007228
(CHEMBL3238219)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cccc(F)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(7.91,-30.88,;7.89,-29.34,;6.55,-28.59,;6.56,-30.1,;9.22,-28.56,;9.2,-27.02,;10.52,-26.23,;10.47,-24.7,;11.68,-23.74,;13.16,-24.16,;11.15,-22.3,;9.6,-22.36,;9.19,-23.83,;8,-22.85,;6.56,-23.38,;6.29,-24.9,;7.48,-25.88,;8.93,-25.35,;4.85,-25.43,;3.67,-24.45,;3.41,-25.96,;4.59,-26.95,;11.92,-20.97,;13.47,-20.98,;14.24,-19.65,;13.48,-18.31,;11.94,-18.3,;11.17,-16.96,;11.16,-19.63,;11.85,-27.02,;11.83,-28.56,;13.15,-29.35,;14.5,-28.59,;14.52,-27.06,;13.19,-26.27,;15.82,-29.39,;15.8,-30.92,;17.16,-28.63,;18.49,-29.42,;19.83,-28.66,;21.22,-29.3,;22.27,-28.17,;21.51,-26.82,;20,-27.13,)| Show InChI InChI=1S/C34H44FN7O2/c1-32(2,3)17-16-27(22-10-12-23(13-11-22)30(43)36-21-28-38-40-41-39-28)42-31(44)29(24-8-7-9-26(35)20-24)37-34(42)18-14-25(15-19-34)33(4,5)6/h7-13,20,25,27H,14-19,21H2,1-6H3,(H,36,43)(H,38,39,40,41)/t25-,27-,34-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-stimulated cAMP production preincubated for 30 mins follo... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Search and Browse
